PM

Punnam Mahendhar

Active Director Director DIN 08411254
DIN 08411254 First appointment May 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2019
Shareholding value •••• Premium profile

About Punnam Mahendhar

Data last updated:

Punnam Mahendhar is a Director at Libramed Pharmaceuticals Private Limited (since 2019). The company operates in Pharma. Libramed Pharmaceuticals Private Limited reported revenue of ₹4.63 Cr (FY 2025).

DIN 08411254
Primary Designation Director
Industry Pharma
First Appointment 01 May 2019
Oldest Company Age 7 yrs
Largest company Libramed Pharmaceuticals Private Limited · ₹4.63 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 May 20192019₹4.63 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Libramed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Punnam Mahendhar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Punnam Mahendhar

Punnam Mahendhar currently holds 1 directorship: Libramed Pharmaceuticals Private Limited (Director, since 01 May 2019, revenue ₹4.63 Cr (FY 2025)).

Punnam Mahendhar was first appointed on 01 May 2019 as Director at Libramed Pharmaceuticals Private Limited.

The current boards of Punnam Mahendhar's companies include Balakrishna Dyavanapelly (Libramed Pharmaceuticals Private Limited), Bharath Gajula (Libramed Pharmaceuticals Private Limited), Latha Sri Bura (Libramed Pharmaceuticals Private Limited), Pannala Mahipal Reddy (Libramed Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available